Comprehensive Analysis of BRCA1, BRCA2 and TP53 Germline Mutation and Tumor Characterization: A Portrait of Early-Onset Breast Cancer in Brazil

BRCA1 testing should be offered to individuals with triple-negative breast cancer diagnosed below 50 years

(2012) L Robertson et al.   BRITISH JOURNAL OF CANCER

BRCA1 mutations in Algerian breast cancer patients: high frequency in young, sporadic cases

(2012) Nancy Uhrhammer et al.   International Journal of Medical Sciences

Patients 35 years old or younger with operable breast cancer are more at risk for relapse and survival: A retrospective matched case–control study

(2011) Roujun Peng et al.   BREAST

Outcome of triple-negative breast cancer in patients with or without deleterious BRCA mutations

(2011) Soley Bayraktar et al.   BREAST CANCER RESEARCH AND TREATMENT

Prognosis and adjuvant treatment effects in selected breast cancer subtypes of very young women (

(2010) G. Cancello et al.   ANNALS OF ONCOLOGY

Estrogen receptor-positive breast carcinomas in younger women are different from those of older women: A pathological and immunohistochemical study

(2010) L.M. Bacchi et al.   BREAST

The prognostic contribution of clinical breast cancer subtype, age, and race among patients with breast cancer brain metastases

(2010) Carey K. Anders et al.   CANCER

Environmental Exposure and Breast Cancer Among Young Women in Rio De Janeiro, Brazil

(2010) Guillermo Patricio Ortega Jacome et al.   JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A-CURRENT ISSUES

p140Cap dual regulation of E-cadherin/EGFR cross-talk and Ras signalling in tumour cell scatter and proliferation

(2010) L Damiano et al.   ONCOGENE

Molecular characterization of breast cancer in young Brazilian women

(2010) Leda Viegas de Carvalho et al.   Revista da Associacao Medica Brasileira

Breast cancer in young women (YBC): prevalence of BRCA1/2 mutations and risk of secondary malignancies across diverse racial groups

(2009) B. G. Haffty et al.   ANNALS OF ONCOLOGY

The prevalence of BRCA1 mutations among young women with triple-negative breast cancer

(2009) SR Young et al.   BMC CANCER

Breast-conserving surgery in 201 very young patients (

(2009) Oreste Gentilini et al.   BREAST

Relationship between age at diagnosis and outcome of premenopausal breast cancer: age less than 35 years is a reasonable cut-off for defining young age-onset breast cancer

(2009) Wonshik Han et al.   BREAST CANCER RESEARCH AND TREATMENT

The prevalence of germ-line TP53 mutations in women diagnosed with breast cancer before age 30

(2009) Ophira M. Ginsburg et al.   Familial Cancer

Detailed haplotype analysis at theTP53locus in p.R337H mutation carriers in the population of Southern Brazil: evidence for a founder effect

(2009) Sonia Garritano et al.   HUMAN MUTATION

Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes

(2009) Joel S. Parker et al.   JOURNAL OF CLINICAL ONCOLOGY

Genes that mediate breast cancer metastasis to the brain

(2009) Paula D. Bos et al.   NATURE

Founder effect of the BRCA1 5382insC mutation in Brazilian patients with hereditary breast ovary cancer syndrome

(2008) E.C.B. da Costa et al.   CANCER GENETICS AND CYTOGENETICS

Young Age at Diagnosis Correlates With Worse Prognosis and Defines a Subset of Breast Cancers With Shared Patterns of Gene Expression

(2008) Carey K. Anders et al.   JOURNAL OF CLINICAL ONCOLOGY